Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
DIABETOLOGY / EXPERIMENTAL RESEARCH
Comparing prophylactic effect of exercise and metformin on cognitive brain functions in rats with type 3 diabetes mellitus
1
Department of Medical Physiology, Kasr Alainy Faculty of Medicine, Cairo University, Egypt
2
Department of Biochemistry, Faculty of Medicine, Cairo University, Egypt
3
Department of Anatomy and Embryology, Faculty of Medicine, Assiut University, Egypt
4
Department of Histology and Cytology, Faculty of Medicine, Alazhar University, Egypt
5
Department of Pathology and Laboratory Medicine, VAMC North East Ohio Healthcare System, Louis Stokes, Cleveland, Ohio, USA
Submission date: 2019-07-29
Final revision date: 2020-03-10
Acceptance date: 2020-03-26
Online publication date: 2020-09-16
Publication date: 2024-04-23
Arch Med Sci 2024;20(2):618-631
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Type 2 diabetes mellitus (DM) and Alzheimer’s disease (AD) are two major medical conditions that constitute a significant financial burden on most healthcare systems. Due to AD sharing “insulin resistance” mechanistic features with DM, some scientists have proposed “type 3 DM” terminology for it. This study aims to compare the prophylactic effect of exercise and metformin on cognitive brain functions in rats with type 3 DM.
Material and methods:
Two groups of rats were included in the study: the control group (n = 15) and the streptozotocin-induced type 2 diabetic group (n = 45). The diabetic group was subdivided into three equal subgroups: a sedentary non-treated diabetic group, an exercised group, and a metformin-treated group. We estimated step-down avoidance task latency, serum glucose, insulin, free fatty acids (FFA), cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL) and triglycerides (TG), brain Aβ-42 and glucose, histological changes by toluidine blue, and immunohistochemistry for brain Aβ-42 and tau-positive cells.
Results:
Serum glucose, FFA, TG, cholesterol, LDL, brain Aβ-42, brain glucose, the number of hippocampal dark and degenerated cells, and brain Aβ-42 and tau-positive cells, were all significantly lower. In contrast, serum insulin and HDL, the number of hippocampal granular cells, and latency of the step-down avoidance task were significantly higher in exercised and metformin-treated groups compared to the diabetic group. There were significantly higher values of serum insulin and brain/plasma glucose ratio and number of brain tau-positive cells in the metformin-treated group than in the exercised group.
Conclusions:
We can conclude that exercise can be as effective as metformin regarding prophylaxis against the deleterious effects of type 3 DM on cognitive brain functions.
Type 2 diabetes mellitus (DM) and Alzheimer’s disease (AD) are two major medical conditions that constitute a significant financial burden on most healthcare systems. Due to AD sharing “insulin resistance” mechanistic features with DM, some scientists have proposed “type 3 DM” terminology for it. This study aims to compare the prophylactic effect of exercise and metformin on cognitive brain functions in rats with type 3 DM.
Material and methods:
Two groups of rats were included in the study: the control group (n = 15) and the streptozotocin-induced type 2 diabetic group (n = 45). The diabetic group was subdivided into three equal subgroups: a sedentary non-treated diabetic group, an exercised group, and a metformin-treated group. We estimated step-down avoidance task latency, serum glucose, insulin, free fatty acids (FFA), cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL) and triglycerides (TG), brain Aβ-42 and glucose, histological changes by toluidine blue, and immunohistochemistry for brain Aβ-42 and tau-positive cells.
Results:
Serum glucose, FFA, TG, cholesterol, LDL, brain Aβ-42, brain glucose, the number of hippocampal dark and degenerated cells, and brain Aβ-42 and tau-positive cells, were all significantly lower. In contrast, serum insulin and HDL, the number of hippocampal granular cells, and latency of the step-down avoidance task were significantly higher in exercised and metformin-treated groups compared to the diabetic group. There were significantly higher values of serum insulin and brain/plasma glucose ratio and number of brain tau-positive cells in the metformin-treated group than in the exercised group.
Conclusions:
We can conclude that exercise can be as effective as metformin regarding prophylaxis against the deleterious effects of type 3 DM on cognitive brain functions.
REFERENCES (84)
1.
Kim DY, Jung SY, Kim TW, Lee KS, Kim K. Treadmill exercise decreases incidence of Alzheimer’s disease by suppressing glycogen synthase kinase-3 expression in streptozotocin-induced diabetic rats. J Exerc Rehabil 2015; 11: 87-94.
2.
Kayar Y, Agin M. The relationship between demographic and anthropometric characteristics and diabetic complications and number of hospitalizations in hospitalized diabetic patients. Arch Med Sci Civil Dis 2019; 4: e7-15.
3.
Sebastião I, Candeias E, Santos MS, de Oliveira CR, Moreira PI, Duarte AI. Insulin as a bridge between type 2 diabetes and Alzheimer disease – how anti-diabetics could be a solution for dementia. Front Endocrinol 2014; 5: 110.
4.
Chang W, Huang D, Lo YM, et al. Protective effect of caffeic acid against Alzheimer’s disease pathogenesis via modulating cerebral insulin signaling, -amyloid accumulation, and synaptic plasticity in hyperinsulinemic rats. J Agric Food Chem 2019; 67: 7684-93.
5.
Nakabeppu Y. Origins of brain insulin and its function. In: Diabetes Mellitus (pp. 1-11). Springer, Singapore 2019.
6.
Konishi M, Sakaguchi M, Lockhart SM, et al. Endothelial insulin receptors differentially control insulin signaling kinetics in peripheral tissues and brain of mice. Proc Natl Acad Sci 2017; 114: E8478-E87.
7.
Reddy PH, Tonk S, Kumar S, et al. A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer’s disease. Biochem Biophys Res Commun 2017; 483: 1156-65.
8.
Stoeckel LE, Arvanitakis Z, Gandy S, et al. Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction. F1000Res 2016; 5: 353.
9.
Kulas JA, Franklin WF, Smith NA, et al. Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues. Am J Physiol Endocrinol Metab 2019; 316: E106-E20.
10.
Karstoft K, Pedersen BK. Exercise and type 2 diabetes: focus on metabolism and inflammation. Immunol Cell Biol 2016; 94: 146-50.
11.
Barnes JN. Exercise, cognitive function, and aging. Adv Physiol Educ 2015; 39: 55-62.
12.
Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35: 1364-79.
13.
Shek A, Alieva R, Kurbanov R, Hoshimov S, Nizamov U, Ziyaeva A. Can metformin stabilize PCSK9 level in stable coronary artery disease patients treated with statins? Arch Med Sci Atheroscler Dis 2019; 4: 144-50.
14.
Koenig AM, Mechanic-Hamilton D, Xie SX, et al. Effects of the insulin sensitizer metformin in Alzheimer’s disease: pilot data from a randomized placebo-controlled crossover study. Alzheimer Dis Assoc Disord 2017; 31: 107-13.
15.
Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia 2017; 60: 1577-85.
16.
Kumar P, Baquer N. Alterations of metabolic parameters and antioxidant enzymes in diabetic aging female rat brain: neuroprotective role of metformin. J Neurol Sci 2017; 381: 573.
17.
Reed MJ, Meszaros K, Entes LJ, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000; 49: 1390-4.
18.
Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008; 22: 659-61.
19.
Kim DY, Jung SY, Kim K, Kim CJ. Treadmill exercise ameliorates Alzheimer disease-associated memory loss through the Wnt signaling pathway in the streptozotocin-induced diabetic rats. J Exerc Rehabil 2016; 12: 276-83.
20.
Henry RJ. Clinical Chemistry, Principles and Technics. Harper and Row Publishers, New York 1964.
21.
Sfa C. 96-well serum/plasma fatty acid kit non-esterified fatty acids detection 1,000 point kit. ZenBio 2010; 692: 1-6.
23.
Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982; 28: 2077-80.
24.
Fray AE, Forsyth RJ, Boutelle MG, Fillenz M. The mechanisms controlling physiologically stimulated changes in rat brain glucose and lactate: a microdialysis study. J Physiol 1996; 496: 49-57.
25.
Best JD, Jay MT, Otu F, et al. Quantitative measurement of changes in amyloid- (40) in the rat brain and cerebrospinal fluid following treatment with the -secretase inhibitor LY-411575 [N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide]. J Pharmacol Exp Ther 2005; 313: 902-8.
26.
Li J, Qi Y, Liu H, et al. Acute high-altitude hypoxic brain injury: identification of ten differential proteins. Neural Regen Res 2013; 8: 2932-41.
27.
Salkovic-Petrisic M, Osmanovic-Barilar J, Brückner MK, Hoyer S, Arendt T, Riederer P. Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer’s disease: a long-term follow up study. J Neural Trans 2011; 118: 765-72.
28.
Jung SY, Kim DY, Yune TY, Shin DH, Baek SB, Kim CJ. Treadmill exercise reduces spinal cord injuryinduced apoptosis by activating the PI3K/Akt pathway in rats. Exp Ther Med 2014; 7: 587-93.
29.
Sung YH, Shin MS, Cho S, et al. Depression-like state in maternal rats induced by repeated separation of pups is accompanied by a decrease of cell proliferation and an increase of apoptosis in the hippocampus. Neurosci Lett 2010; 470: 86-90.
30.
Chan YH. Biostatistics 102: quantitative data – parametric & non-parametric tests. Blood Press 2003; 140: 79.
31.
Wongchitrat P, Lansubsakul N, Kamsrijai U, Sae-Ung K, Mukda S, Govitrapong P. Melatonin attenuates the high-fat diet and streptozotocin-induced reduction in rat hippocampal neurogenesis. Neurochem Int 2016; 100: 97-109.
32.
Medhat E, Rashed L, Abdelgwad M, Aboulhoda BE, Khalifa MM, El-Din SS. Exercise enhances the effectiveness of vitamin D therapy in rats with Alzheimer’s disease: emphasis on oxidative stress and inflammation. Metab Brain Dis 2020; 35: 111-20.
33.
Jung SY, Kim DY. Treadmill exercise improves motor and memory functions in cerebral palsy rats through activation of PI3K-Akt pathway. J Exerc Rehabil 2017; 13: 136-42.
34.
Yi SS. Effects of exercise on brain functions in diabetic animal models. World J Diabetes 2015; 6: 583-97.
35.
Paillard T. Preventive effects of regular physical exercise against cognitive decline and the risk of dementia with age advancement. Sports Med Open 2015; 1: 20.
36.
Chen B, Teng Y, Zhang X, Lv X, Yin Y. Metformin alleviated A-induced apoptosis via the suppression of JNK MAPK signaling pathway in cultured hippocampal neurons. Biomed Res Int 2016; 2016: 1421430.
37.
Oliveira WH, Nunes AK, França MER, et al. Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice. Brain Res 2016; 1644: 149-60.
38.
Grillo CA, Woodruff J, Macht VA, Reagan LP. Insulin resistance and hippocampal dysfunction: disentangling peripheral and brain causes from consequences. Exp Neurol 2019; 318: 71-7.
39.
Olver TD, Laughlin MH, Padilla J. Exercise and vascular insulin sensitivity in the skeletal muscle and brain. Exerc Sport Sci Rev 2019; 47: 66-74.
40.
Liu Y, Liu C, Lu ML, et al. Vibration exercise decreases insulin resistance and modulates the insulin signaling pathway in a type 2 diabetic rat model. Int J Clin Exp Med 2015; 8: 13136-44.
41.
Andrade EF, Lima ARV, Nunes IE, et al. Exercise and beta-glucan consumption (Saccharomyces cerevisiae) improve the metabolic profile and reduce the atherogenic index in type 2 diabetic rats (HFD/STZ). Nutrients 2016; 8: 792.
42.
Wang Q, Hu J, Liu Y, et al. Aerobic exercise improves synaptic-related proteins of diabetic rats by inhibiting FOXO1/NF-B/NLRP3 inflammatory signaling pathway and ameliorating PI3K/Akt insulin signaling pathway J Mol Neurosci 2019; 69: 28-38.
43.
Tan J, Guo L. Swimming intervention alleviates insulin resistance and chronic inflammation in metabolic syndrome. Exp Ther Med 2019; 17: 57-62.
44.
Teixeira-Lemos E, Nunes S, Teixeira F, Reis F. Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties. Cardiovasc Diabetol 2011; 10: 12.
45.
Ding C, Chooi YC, Chan Z, et al. Dose-dependent effects of exercise and diet on insulin sensitivity and secretion. Med Sci Sports Exerc 2019; 51: 2109-16.
46.
Otero-Losada M, Gonzalez J, Müller A, et al. Exercise ameliorates endocrine pancreas damage induced by chronic cola drinking in rats. PLoS One 2016; 11: 0155630.
47.
Wyett G, Gibert Y, Ellis M, Castillo HA, Kaslin J, Aston-Mourney K. Metformin, beta-cell development, and novel processes following beta-cell ablation in zebrafish. Endocrine 2018; 59: 419-25.
48.
Tomkin GH, Owens D. Diabetes and dyslipidemia: characterizing lipoprotein metabolism. Diabetes Metab Syndr Obes 2017; 10: 333-43.
49.
Rutter GA, Pullen TJ, Hodson DJ, Martinez-Sanchez A. Pancreatic -cell identity, glucose sensing and the control of insulin secretion. Biochem J 2015; 466: 203-18.
50.
Edmunds LR, Huckestein BR, Kahn M, et al. Hepatic insulin sensitivity is improved in high-fat diet-fed Park2 knockout mice in association with increased hepatic AMPK activation and reduced steatosis. Physiol Rep 2019; 7: e14281.
51.
Mohammadimanesh A, Vahidiniya AA, Doaei S, et al. The effect of different types of honey on the lipid profile of streptozotocin-induced diabetic rats. Arch Med Sci Atheroscler Dis 2019; 28: e113-8.
52.
Barchuk M, Schreier L, López G, et al. Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 and angiopoietin-like protein 4 are associated with the increase of lipoprotein lipase activity in epicardial adipose tissue from diabetic patients. Atherosclerosis 2019; 288: 51-9.
53.
Spriet LL. New insights into the interaction of carbohydrate and fat metabolism during exercise. Sports Med 2014; 44: 87-96.
54.
Kim JH, Park Y. Combined effects of phytochemicals and exercise on fatty acid oxidation. J Exerc Nutrition Biochem 2016; 20: 20-6.
55.
Iso T, Sunaga H, Matsui H, et al. Serum levels of fatty acid binding protein 4 and fat metabolic markers in relation to catecholamines following exercise. Clin Bioch 2017; 50: 896-902.
56.
Khunti K, Ceriello A, Cos X, De Block C. Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract 2018; 137: 137-48.
57.
Zhao W, Li A, Feng X, et al. Metformin and resveratrol ameliorate muscle insulin resistance through preventing lipolysis and inflammation in hypoxic adipose tissue. Cell Signal 2016; 28: 1401-11.
58.
Tsuzuki T, Shinozaki S, Nakamoto H, et al. Voluntary exercise can ameliorate insulin resistance by reducing iNOS-mediated S-nitrosylation of Akt in the liver in obese rats. PLoS One 2015; 10: 0132029.
59.
Baur JA, Birnbaum MJ. Control of gluconeogenesis by metformin: does redox trump energy charge? Cell Metab 2014; 20: 197-9.
60.
Cai R, Huang R, Han J, et al. Lipoprotein-associated phospholipase A2 is associated with risk of mild cognitive impairment in Chinese patients with type 2 diabetes. Sci Rep 2017; 7: 1-9.
61.
Wang Y, Xu D. Effects of aerobic exercise on lipids and lipoproteins. Lipids Health Dis 2017; 16: 132.
62.
Wang J, Gao Y, Duan L, et al. Metformin ameliorates skeletal muscle insulin resistance by inhibiting miR-21 expression in a high-fat dietary rat model. Oncotarget 2017; 8: 98029.
63.
Tofighi A, Rahmani F, Qarakhanlou BJ, Babaei S. The effect of regular aerobic exercise on reverse cholesterol transport A1 and apo lipoprotein aI gene expression in inactive women. Iran Red Crescent Med J 2015; 17: 326321.
64.
Zhang S, Xu H, Yu X, Wu YI, Sui D. Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes. Exp Ther Med 2017; 14: 383-90.
65.
Kamenova P. Therapeutic potential of metformin in normal glucose tolerant persons with metabolic syndrome. Biotechnol Biotechnologic Equip 2020; 34: 30-7.
66.
Yang L, Wu, Wang B, Bu X, Zhu J, Tang J. The effects of hyperbilirubinaemia on synaptic plasticity in the dentate gyrus region of the rat hippocampus in vivo. Arch Med Sci 2019; 16: 200-4.
67.
Sadeghi A, Hami J, Razavi S, Esfandiary E, Hejazi Z. The effect of diabetes mellitus on apoptosis in hippocampus: cellular and molecular aspects. Int J Prev Med 2016; 7: 57.
68.
Kahya MC, Nazıroğlu M, Övey İS. Modulation of diabetes-induced oxidative stress, apoptosis, and Ca 2+ entry through TRPM2 and TRPV1 channels in dorsal root ganglion and hippocampus of diabetic rats by melatonin and selenium. Mol Neurobiol 2017; 54: 2345-60.
69.
Fritsch M, Günther SD, Schwarzer R, et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature 2019; 575: 683-7.
70.
Yan W, Pang M, Yu Y, et al. The neuroprotection of liraglutide on diabetic cognitive deficits is associated with improved hippocampal synapses and inhibited neuronal apoptosis. Life Sci 2019; 231: 116566.
71.
Yonguc GN, Dodurga Y, Adiguzel E, et al. Grape seed extract has superior beneficial effects than vitamin E on oxidative stress and apoptosis in the hippocampus of streptozotocin induced diabetic rats. Gene 2015; 555: 119-26.
72.
Jafari Anarkooli I, Sankian M, Ahmadpour S, Varasteh AR, Haghir H. Evaluation of Bcl-2 family gene expression and Caspase-3 activity in hippocampus STZ-induced diabetic rats. Exp Diabetes Res 2008; 2008: 638467.
73.
Karunakaran U, Park KG. A systematic review of oxidative stress and safety of antioxidants in diabetes: focus on islets and their defense. Diabetes Metab J 2013; 37: 106-12.
74.
Oyenihi AB, Ayeleso AO, Mukwevho E, Masola B. Antioxidant strategies in the management of diabetic neuropathy. Biomed Res Int 2015; 2015: 515042.
75.
Devi L, Alldred MJ, Ginsberg SD, Ohno M. Mechanisms underlying insulin deficiency-induced acceleration of -amyloidosis in a mouse model of Alzheimer’s disease. PLoS One 2012; 7: e32792.
76.
Busquets O, Ettcheto M, Pallàs M, et al. Long-term exposition to a high fat diet favors the appearance of -amyloid depositions in the brain of C57BL/6J mice. A potential model of sporadic Alzheimer’s disease. Mech Ageing Dev 2017; 162: 38-45.
77.
MacPherson RE, Baumeister P, Peppler WT, Wright DC, Little JP. Reduced cortical BACE1 content with one bout of exercise is accompanied by declines in AMPK, Akt, and MAPK signaling in obese, glucose-intolerant mice J Appl Physiol (1985) 2015; 119: 1097-104.
78.
Lin TW, Shih YH, Chen SJ, et al. Running exercise delays neurodegeneration in amygdala and hippocampus of Alzheimer’s disease (APP/PS1) transgenic mice. Neurobiol Learn Mem 2015; 118: 189-97.
79.
Zeng B, Zhao G, Liu HL. The differential effect of treadmill exercise intensity on hippocampal soluble a and lipid metabolism in APP/PS1 mice. Neuroscience 2020; 430: 73-81.
80.
Chiang MC, Cheng YC, Chen SJ, Yen CH, Huang RN. Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction. Exp Cell Res 2016; 347: 322-31.
81.
Markowicz-Piasecka M, Sikora J, Mateusiak Ł, Mikiciuk-Olasik E, Huttunen KM. New prodrugs of metformin do not influence the overall haemostasis potential and integrity of the erythrocyte membrane. Eur J Pharm 2017; 811: 208-21.
82.
Moran C, Beare R, Phan TG, Bruce DG, Callisaya ML, Srikanth V. Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology 2015; 85: 1123-30.
83.
Zhang Y, Huang NQ, Yan F, et al. Diabetes mellitus and Alzheimer’s disease: GSK-3 as a potential link. Behav Brain Res 2018; 339: 57-65.
84.
Yang Y, Ma D, Wang Y, et al. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes. J Alzheimers Dis 2013; 33: 329-38.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
